226 related articles for article (PubMed ID: 11431448)
1. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice.
Hori J; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1820-8. PubMed ID: 11431448
[TBL] [Abstract][Full Text] [Related]
2. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
Hori J; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
[TBL] [Abstract][Full Text] [Related]
3. Survival of donor-derived cells in human corneal transplants.
Lagali N; Stenevi U; Claesson M; Fagerholm P; Hanson C; Weijdegård B;
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2673-8. PubMed ID: 19151390
[TBL] [Abstract][Full Text] [Related]
4. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
Hori J; Joyce NC; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
6. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
Sonoda Y; Sano Y; Ksander B; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
[TBL] [Abstract][Full Text] [Related]
9. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
Osawa H; Maruyama K; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
[TBL] [Abstract][Full Text] [Related]
10. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
[TBL] [Abstract][Full Text] [Related]
11. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
12. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
13. Cytokine expression during orthotopic corneal allograft rejection in mice.
Sano Y; Osawa H; Sotozono C; Kinoshita S
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1953-7. PubMed ID: 9727419
[TBL] [Abstract][Full Text] [Related]
14. Host-derived endothelial regeneration of corneal transplants in a rat keratoplasty model.
Bredow L; Schwartzkopff J; Reinhard T
Ophthalmic Res; 2014; 52(2):60-4. PubMed ID: 24993185
[TBL] [Abstract][Full Text] [Related]
15. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
Hargrave SL; Mayhew E; Hegde S; Niederkorn J
Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
[TBL] [Abstract][Full Text] [Related]
16. Donor and recipient endothelial cell population of the transplanted human cornea: a two-dimensional imaging study.
Lagali N; Stenevi U; Claesson M; Fagerholm P; Hanson C; Weijdegård B; Strömbeck AS;
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1898-904. PubMed ID: 19815734
[TBL] [Abstract][Full Text] [Related]
17. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
Hori J; Joyce N; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
[TBL] [Abstract][Full Text] [Related]
18. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
19. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium.
Hori J; Streilein JW
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):658-64. PubMed ID: 12556396
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
